ORENCIA 125 mg solution for injection in pre-filled syringe

Company
Bristol-Myers Squibb Pharma EEIG
Active Ingredient
Dosage Form
Solution for injection in prefilled syringe
Legal Category
A - prescription, may not be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/07/389/004 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
EU/1/07/389/005 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
EU/1/07/389/006 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
EU/1/07/389/007 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
EU/1/07/389/008 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
EU/1/07/389/009 125 milligram(s) L04AA24 Solution for injection in prefilled syringe
Licence number
EU/1/07/389/004
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe
Licence number
EU/1/07/389/005
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe
Licence number
EU/1/07/389/006
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe
Licence number
EU/1/07/389/007
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe
Licence number
EU/1/07/389/008
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe
Licence number
EU/1/07/389/009
Strength
125 milligram(s)
ATC Code
L04AA24
Dosage Form
Solution for injection in prefilled syringe

Bristol-Myers Squibb Pharma EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

Telephone
+3531800749749
Email
medical.information@bms.com